Cell chain of custody is the documented trail of who collected, handled, stored, transported, and administered a cell product. Linked identifiers connect the dose to its source and record each handover. For a patient, the practical question is whether the clinic can connect the dose label to the collection record, processing history, and relevant test results.
What the Records Show
A useful custody record identifies the material, who handed it over and received it, when the transfer happened, and any relevant handling conditions or deviations. A collection code, processing batch number, and final dose identifier do not have to be identical, but their connections must be documented so the trail can be followed without guessing.

Traceability supports identification and investigation. It does not, by itself, prove that a cell product is uncontaminated, suitable for you, or effective for your condition.
How the Chain Works
The following seven stages are a practical checklist, not a universal manufacturing protocol. Processing, testing, and storage arrangements depend on the product.
- Collection. Someone takes a tissue sample, either from you (autologous) or from a donor (allogeneic). The collection is logged with a code rather than a vague note, along with the date, the tissue type, and who took the sample.
- Labeling and handover. Staff tag the container with a unique identifier at the collection site, and each handoff after that is signed off.
- Processing. Where applicable, records describe steps such as separating or expanding cells. They link the starting material to the resulting batch and the dose prepared from it.
- Testing. Contamination checks and counts of how many cells were alive when tested belong to that same batch number. Results from a different batch do not describe your dose.
- Storage. Records should show the specified storage conditions, relevant monitoring results, and any deviations or moves between storage units.
- Transport. Packing, departure and arrival times, and receipt checks are documented. Cells can spoil or get mixed up during shipment, which is why the trip is logged as well.
- Administration. Before administration, staff match the labeled dose to you as the intended recipient, and they record that the dose was given.
General information for adults, not personal medical advice. If you are considering treatment, discuss your own situation with a qualified medical professional.
Why It Matters
Wrong-Patient Errors
When one site holds cells from more than one person, a labeling slip can send one person’s material to someone else. With your own cells, a swap would still leave you receiving material that never came from you. The safeguard is to check the code at each step.
Untraceable Problems
If contamination is detected or storage conditions fail, staff need to identify the affected material and anyone who received it. U.S. tracking rules illustrate this purpose: establishments performing a manufacturing step in which they handle a human cell, tissue, or cellular or tissue-based product (HCT/P) must track it to support investigation of actual or suspected communicable-disease transmission and timely corrective action.Section 1271.290
A 2018 CDC investigation illustrates the value of source records. As of December 14, infections had been reported in 12 patients across three U.S. states after they received contaminated umbilical cord blood-derived products distributed by Liveyon and processed by Genetech. All were hospitalized; the products were not FDA-approved or lawfully marketed.Mm6750a5.htm Six unopened vials tested from Texas shared the cord-blood donor and processing date of products administered to patients with infections. All six grew Enterobacter cloacae.Mm6750a5.htm This supports the need to link products to their source; it does not establish that a custody-record failure caused the contamination.
Unverifiable Claims
Claims about careful testing cannot be checked without paperwork. If the clinic cannot show records filed under your batch number, you have no way to test those claims against your dose.
What a Complete Chain Includes
- An identifier assigned at collection, with documented links to any later batch or dose identifiers.
- A batch number for your dose that leads back to the starting material, the processing steps, and the test results for that same batch.
- Written handover records showing who held the material at each stage, including transport and receipt.
- Storage and shipping logs that record any break from the target conditions instead of leaving blanks.
- A final identity check before administration that matches the labeled product to you.
In the U.S. example, 21 CFR 1271.290 requires tracking from donor to consignee or final disposition and back. It also requires a distinct identification code linking the HCT/P to its donor and records. That tracking code must not include a name, Social Security number, or medical record number.Section 1271.290 These are U.S. requirements, not a statement of Japanese law.
A clinic’s general process description does not verify your dose. Ask for the records or an explanation showing how its identifiers and test results connect to the product intended for you, without requesting another donor’s personal details.
Terms People Confuse
| Term | What it is | Why it is not the same thing |
|---|---|---|
| Cell identity | Which cells are actually in the container, established through source records plus lab tests | One link in the chain; the chain also covers handling, storage, and handovers |
| Cell processing center (CPC) | The facility or function where cells are prepared | A place and an activity; the chain is the traceability record across places |
| Regulatory filing or facility notification | A filed treatment plan or facility registration under a framework such as Japan’s regenerative medicine safety framework | A regulatory status; a filing is not proof that the chain was followed for your batch, and it is not proof that a treatment works |
| Product approval | Authorization of a named product for specified uses and conditions after regulatory review | It does not extend to every preparation with a similar name or every proposed use |
Japan’s framework keeps these routes separate: the Act on the Safety of Regenerative Medicine covers the medical-practice side, while the PMD Act governs the commercialization of regenerative medical products.0003
What It Cannot Prove
Custody records alone cannot establish:
- Whether these cells suit your condition.
- Whether the treatment works. That question needs clinical evidence on that exact treatment, not forms.
- That a dose is free of contamination. The relevant tests and their limits need separate assessment.
- That the product met every requirement for release. Ask which criteria applied and whether the records show they were met.
Questions to Ask
- What identifier links my dose back to the original collection, and can you show me how the batch number connects to it?
- Which processing steps were applied to this batch, and which test results belong to this same batch?
- How were the cells stored and transported, and were there any deviations from the intended conditions?
- What final check matches the labeled dose to me before administration?
- Is this offer a filed treatment plan, use of an approved product for its approved use, or participation in research? What documents correspond to my exact treatment?
A Document-Matching Example
Suppose the dose label uses one identifier and the test report uses another. That difference alone does not prove a mix-up. Ask staff to show the record connecting the two. Then check whether the report describes the material tested and when the sample was taken. A result for an unrelated batch cannot answer a question about your dose.
This is an illustrative checking scenario, not a report of a patient case or a review of a particular clinic’s records. Matching identifiers is a starting point; it cannot authenticate the records or replace professional assessment. If staff cannot explain the links or a recorded deviation, pause the decision and seek clarification from the treating team or an independent medical professional.
Have questions about which treatment documents to request? Contact the patient support team.
The Bottom Line
Cell chain of custody answers whose material it is, who handled it, and how it reached the intended recipient. Ask for the linked records for your dose, then assess the treatment’s clinical evidence, risks, and regulatory status separately. A traceable dose is not, by itself, a proven treatment.




